ATE365034T1 - Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether- verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung - Google Patents

Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether- verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung

Info

Publication number
ATE365034T1
ATE365034T1 AT04737744T AT04737744T ATE365034T1 AT E365034 T1 ATE365034 T1 AT E365034T1 AT 04737744 T AT04737744 T AT 04737744T AT 04737744 T AT04737744 T AT 04737744T AT E365034 T1 ATE365034 T1 AT E365034T1
Authority
AT
Austria
Prior art keywords
compound
fluorether
stabilizing
degradation
stable pharmaceutical
Prior art date
Application number
AT04737744T
Other languages
English (en)
Inventor
Ogari Pacheco
Elisa Russo
Valter Russo
Jose Antonio Martins
Maria Alice Bockelmann
Simone Rosatto
Original Assignee
Cristalia Prod Quimicos Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BR0303489A external-priority patent/BR0303489A/pt
Priority claimed from BRPI0405842A external-priority patent/BRPI0405842B8/pt
Application filed by Cristalia Prod Quimicos Farm filed Critical Cristalia Prod Quimicos Farm
Application granted granted Critical
Publication of ATE365034T1 publication Critical patent/ATE365034T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04737744T 2003-09-10 2004-08-20 Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether- verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung ATE365034T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR0303489A BR0303489A (pt) 2003-09-10 2003-09-10 Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter
BRPI0405842A BRPI0405842B8 (pt) 2004-07-29 2004-07-29 composição farmacêutica estabilizada de composto flúor-éter para uso anestésico. método para estabilizar um composto flúor-éter. uso de agente estabilizante para impedir a degradação de composto flúor éter.

Publications (1)

Publication Number Publication Date
ATE365034T1 true ATE365034T1 (de) 2007-07-15

Family

ID=37450729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04737744T ATE365034T1 (de) 2003-09-10 2004-08-20 Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether- verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung

Country Status (11)

Country Link
US (1) US7816409B2 (de)
EP (1) EP1663186B1 (de)
JP (1) JP4253343B2 (de)
AT (1) ATE365034T1 (de)
DE (1) DE602004007149T2 (de)
ES (1) ES2289524T3 (de)
HK (1) HK1108633A1 (de)
MX (1) MXPA06000803A (de)
PL (1) PL1663186T3 (de)
PT (1) PT1663186E (de)
WO (1) WO2005023175A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06000803A (es) 2003-09-10 2006-08-23 Cristalia Prod Quimicos Farm Composicion farmaceutica estable del compuesto de fluoroeter para uso anestesico, metodo para estabilizar un compuesto de fluoroeter, uso del agente estabilizador para evitar la degradacion de un compuesto de fluoroeter.
AP2007004229A0 (en) * 2005-04-18 2007-12-31 Minrad Inc Preparation of sevoflurane with negligible water content
PL2244737T3 (pl) 2008-01-22 2020-05-18 The Board Of Regents Of The University Of Texas System Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu
AU2015200210B2 (en) * 2008-01-22 2016-08-11 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
US20090275785A1 (en) 2008-05-01 2009-11-05 Barry Jones Distillation Method For The Purification Of Sevoflurane And The Maintenance Of Certain Equipment That May Be Used In The Distillation Process
AU2010245932B2 (en) * 2009-05-05 2015-08-06 Board Of Regents, The University Of Texas System Novel formulations of volatile anesthetics and methods of use for reducing inflammation
US9102604B1 (en) 2010-02-15 2015-08-11 Baxter International Inc. Methods for cleaning distilling columns
ES2873964T3 (es) * 2013-03-15 2021-11-04 Newvapogen Inc Nuevas composiciones analgésicas
CN105106182B (zh) * 2015-09-21 2017-12-29 山东新时代药业有限公司 七氟烷吸入剂
CN105193774B (zh) * 2015-09-21 2018-01-16 山东新时代药业有限公司 一种七氟烷吸入剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3216897A (en) * 1961-11-02 1965-11-09 Air Reduction Injectable anesthetic
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
US6162443A (en) * 1998-01-09 2000-12-19 Abbott Laboratories Container for an inhalation anesthetic
US6074668A (en) 1998-01-09 2000-06-13 Abbott Laboratories Container for an inhalation anesthetic
US6271422B1 (en) * 2000-06-01 2001-08-07 Abbott Laboratories Method for fluoromethylation of alcohols via halogenative decarboxylation
ATE429947T1 (de) * 2001-08-29 2009-05-15 Pharmakodex Ltd Vorrichtung zur topischen verabreichung
GB0124071D0 (en) 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics
CA2476589C (en) * 2002-02-27 2014-02-25 Pharmain, Ltd. Compositions for delivery of therapeutics and other materials, and methods of making and using the same
MXPA06000803A (es) * 2003-09-10 2006-08-23 Cristalia Prod Quimicos Farm Composicion farmaceutica estable del compuesto de fluoroeter para uso anestesico, metodo para estabilizar un compuesto de fluoroeter, uso del agente estabilizador para evitar la degradacion de un compuesto de fluoroeter.

Also Published As

Publication number Publication date
US7816409B2 (en) 2010-10-19
EP1663186A2 (de) 2006-06-07
ES2289524T3 (es) 2008-02-01
US20060228383A1 (en) 2006-10-12
DE602004007149D1 (de) 2007-08-02
DE602004007149T2 (de) 2008-02-28
JP2007505047A (ja) 2007-03-08
JP4253343B2 (ja) 2009-04-08
WO2005023175A2 (en) 2005-03-17
MXPA06000803A (es) 2006-08-23
PL1663186T3 (pl) 2007-11-30
WO2005023175A3 (en) 2005-08-04
WO2005023175B1 (en) 2005-09-09
EP1663186B1 (de) 2007-06-20
PT1663186E (pt) 2007-09-27
HK1108633A1 (en) 2008-05-16

Similar Documents

Publication Publication Date Title
HK1108633A1 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
CY1121782T1 (el) Διαδικασια για ξηρανση της bibw2992, tων αλατων αυτης και στερεων φαρμακευτικων σκευασματων που περιλαμβανουν αυτο το δραστικο συστατικο
CY1109457T1 (el) Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει
RU2012142356A (ru) Продукт для ухода за полостью рта и способы его применения и получения
CY1118179T1 (el) Φαρμακευτικη συνθεση
TW200735773A (en) Insecticidal compositions with improved activity
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0813044A2 (pt) "composto, composição fungicida e método para o controle do fungo fitopatogênico de culturas"
TW200730178A (en) Aerosol formulations for the inhalation of β-agonists
CL2004000917A1 (es) Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
ATE528990T1 (de) Desinfektions- und entkeimungsmittel
WO2013117770A3 (en) Cosmetic treatment method, and composition comprising a glyoxylic acid ester
AR078318A1 (es) Compuestos carbonatos de anti-biopelicula para su uso en composiciones de cuidado oral
AR056558A1 (es) Metodos para estabilizar composiciones oftalmicas
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
UY27980A1 (es) Indoles 2,7-sustituidos
UA87312C2 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
NZ601139A (en) Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
WO2012136818A3 (en) Cosmetic composition comprising a cucurbic acid compound and a blend of acrylic polymers
MY157743A (en) Emulsion-type liquid composition for oral cavity and process for production thereof
ATE336230T1 (de) Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
WO2009139901A3 (en) Methods and compositions for improving cognitive function
SE0403118D0 (sv) New compounds 2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties